| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 565238-13-3 | 7-Azatricyclo[4.3.0.03,9]Nonane | C8H13N |
| 565238-59-7 | 2-Ethyl-3-Hydroxy-1-(2-Pyridinylmethyl)-4(1H)-Pyridinone | C13H14N2O2 |
| 565238-60-0 | 2-Ethyl-3-Hydroxy-1-(3-Pyridinylmethyl)-4(1H)-Pyridinone | C13H14N2O2 |
| 565238-61-1 | 2-Ethyl-3-Hydroxy-1-(4-Pyridinylmethyl)-4(1H)-Pyridinone | C13H14N2O2 |
| 565434-20-0 | 5-Hydroxy-3-[(1S)-1-Hydroxyethyl]-4-Methyl-2(5H)-Furanone | C7H10O4 |
| 565434-40-4 | 3-[(1S)-1-Hydroxypropyl]-4-Methyl-2(5H)-Furanone | C8H12O3 |
| 565434-41-5 | 3-[(1R)-1-Hydroxypropyl]-4-Methyl-2(5H)-Furanone | C8H12O3 |
| 565434-85-7 | CBP501 | |
| 565435-37-2 | 5-Hydroxy-3-[(1R)-1-Hydroxyethyl]-4-Methyl-2(5H)-Furanone | C7H10O4 |
| 565448-78-4 | 2-[(3-Methylbutyl)Amino]Nicotinic Acid | C11H16N2O2 |
| 565450-78-4 | 2'-C-Methyl-6-O-methylinosine | C12H16N4O5 |
| 565451-13-0 | Raxibacumab | |
| 565452-98-4 | (2R)-1-(Chloroacetyl)-2-pyrrolidinecarbonitrile | C7H9ClN2O |
| 565453-22-7 | 1-(2-Benzothiazolyl)-4-piperidinamine | C12H15N3S |
| 565453-39-6 | N-(3-Hydroxytricyclo[3.3.1.1(3,7)]dec-1-yl)glycyl-L-prolinamide | C17H27N3O3 |
| 565453-40-9 | N-(3-Hydroxytricyclo[3.3.1.1(3,7)]dec-1-yl)glycyl-L-proline | C17H26N2O4 |
| 565453-41-0 | Vildagliptin Impurity 3 Trifluoroacetate | C17H26N2O4. C2HF3O2 |
| 565453-80-7 | 3-Methyl-2-Oxo-2,3-Dihydro-1H-Pyrrolo[1,2-a]Imidazole-6-Carbonitrile | C8H7N3O |
| 565454-88-8 | ER-805751 | |
| 565456-75-9 | 2-(Tert-Butoxycarbonylamino)-3-Cyclobutyl-Propanoic Acid | C12H21NO4 |
| 565456-77-1 | Methyl (1R,2S,5S)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylate hydrochloride | C9H15NO2.HCl |
| 565457-61-6 | 3-(1-(4-(diethylamino)phenyl)-2,2-bis(1-ethyl-2-methyl-1H-indol-3-yl)vinyl)isobenzofuran-1(3H)-one | C42H43N3O2 |
| 565460-15-3 | N-[1,1'-Biphenyl]-3-ylcarbamic acid cyclohexyl ester | C19H21NO2 |
| 565461-05-4 | (3R)-3-Amino-4-Ethoxy-4-Oxobutanoic Acid | C6H11NO4 |
| 565464-16-6 | (1E,3Z,5E,7Z)-9,9-Difluoro-1,3,5,7-Cyclononatetraene | C9H8F2 |
| 565470-86-2 | 1H-[1,2,4]Thiadiazino[4,3-a]Benzimidazole | C9H7N3S |
| 565470-94-2 | 6,6-Dimethylquinuclidin-2-One | C9H15NO |
| 565471-90-1 | Methyl 2-(N-phthalimidomethyl)-3-oxobutyrate | C14H13NO5 |
| 566143-95-1 | 3,6-Diiodo-9-(4-methylphenyl)-9H-carbazole | C19H13I2N |
| 566149-87-9 | 2,4-Dimethyl-1,4-Dihydrocyclopenta[b]Indol-3(2H)-One | C13H13NO |
| 566151-55-1 | (4R,4aR,7aR)-4-Methyl-4,4A,5,6,7,7A-Hexahydro-3H-Cyclopenta[b]Pyridin-2-Amine | C9H16N2 |
| 566151-72-2 | (1R,2S,6R)-2-Methyl-5-Azabicyclo[4.1.0]Heptan-4-One | C7H11NO |
| 566151-87-9 | (1R,5R,6R)-5-Methyl-2-Azabicyclo[4.1.0]Heptan-3-One | C7H11NO |
| 566154-63-0 | 1-(3-Fluorophenyl)-5-Oxo-3-Pyrrolidinecarboxylic Acid | C11H10FNO3 |
| 566154-69-6 | 1-(2,3-Dihydro-1H-Inden-2-Yl)-5-Oxo-3-Pyrrolidinecarboxylic Acid | C14H15NO3 |
| 566155-23-5 | N-Allyl-N-Methyl-2-Oxopropanamide | C7H11NO2 |
| 566155-27-9 | (2E)-N-Allyl-2-(Hydroxyimino)-N-Methylpropanamide | C7H12N2O2 |
| 566155-29-1 | (2Z)-N-Allyl-2-(Hydroxyimino)-N-Methylpropanamide | C7H12N2O2 |
| 566155-30-4 | 3,5-Dimethyl-5,6-Dihydro-2(1H)-Pyrazinone 4-Oxide | C6H10N2O2 |
| 566155-32-6 | 1,3,5-Trimethyl-5,6-Dihydro-2(1H)-Pyrazinone 4-Oxide | C7H12N2O2 |
| 566155-33-7 | (3aR,6aR)-5,6A-Dimethylhexahydro-6H-Pyrrolo[3,4-c][1,2]Oxazol-6-One | C7H12N2O2 |
| 566155-76-8 | alpha,alpha-Dimethyl-4-Pyridinemethanamine | C8H12N2 |
| 566155-78-0 | 2-(6-Methyl-3-Pyridinyl)-2-Propanamine | C9H14N2 |
| 566156-01-2 | 2-Methyl-1-(2-Pyridinyl)-2-Propanamine | C9H14N2 |
| 566156-02-3 | 2-Methyl-1-(3-Pyridinyl)-2-Propanamine | C9H14N2 |
| 566156-03-4 | Methyl (1R,2S)-2-Amino-2-Methylcyclopentanecarboxylate | C8H15NO2 |
| 566156-04-5 | [(1S,2R)-2-Amino-2-Methylcyclopentyl]Methanol | C7H15NO |
| 566157-11-7 | 1-Methoxy-5-Indanecarbonitrile | C11H11NO |
| 566157-94-6 | 2-Methyl-1-(4-Pyridinyl)-2-Propanamine | C9H14N2 |
| 566157-95-7 | Methyl (1S,2R)-2-Amino-2-Methylcyclopentanecarboxylate | C8H15NO2 |